26.04.2012
- Financier Carl Icahn said he has voluntarily dismissed a lawsuit filed against Amylin Pharmaceuticals after talking with the biotech company's chief executive, Daniel Bradbury...
25.04.2012
- Syngenta and Novozymes announced a global agreement under which Syngenta will work with Novozymes to commercialize the Novozymes technology JumpStart, a seed-applied biological...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
25.04.2012
- German industrial conglomerate Evonik may put its planned second-quarter listing on ice if valuations in the chemical sector remain at current levels, two sources close to the...
24.04.2012
- Industrial gas supplier Air Products and Chemicals's quarterly profit just missed Wall Street's expectations as weak economic conditions in Europe dented volumes. In the second...
24.04.2012
- Chemical maker Ashland posted higher-than-expected quarterly profit as it sold more adhesives and coatings. The company makes a wide range of specialty chemicals, including...
24.04.2012
- Celanese said that its quarterly profit rose 29% due to strong sales of chemicals used to make glues and fibers. For the first quarter, the company posted net income of $183...
24.04.2012
- Rhodia, member of the Solvay group, and Tantalus Rare Earths are pleased to announce the signing of a Letter of Intent ("LOI") relating to technical cooperation for the development...
24.04.2012
- Seven months after the acquisition of Rhodia, Solvay today presented the group's strategic vision focused on value creation and its profitability ambition for 2016. The major...
- Optimized by nature over the millennia, enzymes are catalysts that play a crucial role in the transformation and degradation of essential molecules in living organisms...
